Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?

Pia Kjaer KristensenV EhrensteinN ShettyA B Pedersen

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2019)

Less than one-third of hip fracture patients had dispensing of anti-osteoporosis medication up to 1 year after hip fracture. We observed only a slight increase in dispensing after hip fracture over the study period, irrespective of patient sex, age, and comorbidity at the time of hip fracture.

Keyphrases

hip fracture
postmenopausal women
end stage renal disease
bone mineral density
healthcare
ejection fraction
newly diagnosed
prognostic factors
case report
patient reported outcomes
body composition